Remove DNA Remove In-Vitro Remove In-Vivo Remove Sales
article thumbnail

News from AACR 2024: Sunday’s highlights

Drug Discovery World

In December 2023, Pfizer announced that it had chosen to donate the rights of its royalties from the sale of Bavencio (avelumab) in the United States to the AACR, as an acknowledgment of the AACR’s dedication to sustained innovation in cancer research and treatment.

In-Vivo 52
article thumbnail

Could CRISPR cure HIV? US biotech Excision raises $60m to find out

pharmaphorum

Once someone is infected with HIV it stays with them for life thanks to the retrovirus’s ability to inject its DNA code into the host. CEO is Daniel Dornbusch, who used to be Americas sales director for Novartis and CEO and co-founder of US cancer biotech Acteris.